Heska Corporation

    Heska Corporation

    NNASDAQ:HSKA
    119.99
    USD
    +0.05
    (+0.04%)
    No data availableFinancial data will appear here once available

    Capital Structure

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Working Capital

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Quarterly Revenue

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Quarterly Earnings Per Share

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Quarterly Dividends Per Share

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Company Description

    Address
    Similar Companies
    Business

    Company News

    • Dalan Animal Health Ships First Honey Bee Vaccine to Tauzer Apiaries, Potentially Protecting 25 Million Bees.

    • HESKA CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Heska Corporation - HSKA

    • Heska (HSKA) Q1 Earnings and Revenues Lag Estimates

    • HESKA CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Heska Corporation - HSKA

    • SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HSKA, LSI, EXR, DFFN

    • Why Heska Stock Is On Fire Today

    • HSKA STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Heska Corporation Is Fair to Shareholders

    • Heska Corporation (HSKA) Q4 2022 Earnings Call Transcript

    • Heska (HSKA) Q4 Earnings and Revenues Surpass Estimates

    • Heska (HSKA) Moves to Buy: Rationale Behind the Upgrade

    • Heska Corp's CEO Loads Up on Shares After 70% Nosedive

    • Heska (HSKA) Moves 9.0% Higher: Will This Strength Last?

    • First-in-Class Honeybee Vaccine Receives Conditional License from the USDA Center for Veterinary Biologics

    • Heska Corporation (HSKA) Q3 2022 Earnings Call Transcript

    • Heska Corp (HSKA) CEO Kevin Wilson on Q2 2022 Results - Earnings Call Transcript

    • 5 Toxic Stocks That May Prove Hazardous for Your Portfolio

    • Heska Corp (HSKA) CEO Kevin Wilson on Q1 2022 Results - Earnings Call Transcript

    • Heska (HSKA) Misses Q1 Earnings and Revenue Estimates

    • VolitionRx strikes exclusive $28M deal with Heska Corp to sell its Nu.Q vet cancer screening test

    • Heska Corporation's (HSKA) CEO Kevin Wilson on Q4 2021 Results - Earnings Call Transcript